Research we are currently funding:
This project aims to show that certain nerve growth factors (proteins that stimulate the growth of nerves) are effective biomarkers for prostate cancer.
This project will lead to a clinical trial of a developed test to ensure the right patients receive and benefit from focal therapy for prostate cancer.
Associate Professor Holst's team are working on a new type of anti-cancer drug that can ‘starve’ prostate cancer cells and stop their growth.
Impact we've achieved with our research:
Tony Maxwell talks about his involvement in cancer support groups and representing consumers in deciding what research Cancer Council funds.
Dr Nair-Shalliker's research is focussed on identifying environmental, lifestyle and molecular risk factors of prostate cancer, including sun exposure, using various population-based dataset
Researchers at Cancer Council NSW found that compared to the general population, men who survived melanoma have a higher risk of being diagnosed with prostate cancer later in life.
Dr Nair-Shalliker's study also found that adult body size, sexual activity and adolescent sexual development are among the factors that appear to raise the risk of prostate cancer.
After losing both parents to cancer James Freeman started Sh*tbox Rally, to date raising almost $12million for cancer research.